Summary
For Year 2026-27, Panacea Biotec reports the following shareholding: Total Promoters at 72.48%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 1.6%, Domestic Institutional Investors at 1.97%, and Retail at 23.96%. This breakdown provides a quick snapshot of ownership distribution for Panacea Biotec in 2026-27.
Panacea Biotec FAQs
As of 04-2026, the promoter shareholding in Panacea Biotec stands at 72.48% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Panacea Biotec is 1.6% and 1.97% respectively.
The retail shareholding of the Panacea Biotec is 23.96%.
Changes in shareholding patterns of Panacea Biotec can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Panacea Biotec are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
